The future of the Texas Compassionate Use Program, which will allow some physicians to treat epilepsy with cannabinoid-based drugs, is right here at the Texas Medical Center.
At a meeting in early January, Vyripharm Biopharmaceuticals explained to a group of politicians, decision makers and medical cannabinoid advocates how the company is educating the state legislature on the best way to implement the program.
The Texas Compassionate Use Act, signed into law on June 1, 2015, created a state licensing program for “dispensing organizations” to provide cannabis-based drugs and for doctors prescribing the drugs to join a physician registry and share information about dosages and administration.
As of December 2017, three dispensing organizations were chosen, and the companies are expected to begin dispensing in early 2018, according to media reports. Vyripharm, located in the TMC Innovation Institute’s TMCx+ incubator space, is assisting with setting the standards and guidelines for the companies as the Compassionate Use Program gets underway.
As part of the meeting, guests toured the company’s research laboratories at The University of Texas MD Anderson Cancer Center and the Medical Botanical Center of Excellence at the University of Houston’s Innovation Center in partnership with Shimadzu, a scientific instruments company.
“The Medical Botanical Center of Excellence is the first fully-comprehensive pharmaceutical and medical botanical testing blockchain platform in Texas,” Elias Jackson, Ph.D., director of scientific public relations at Vyripharm, said. “This has been four years in the making and will allow patients to have pharmaceutical grade cannabinoid products across the board.”
Vyripharm aims to set the standard in the implementation of Compassionate Use programs across the country. The center’s facility follows the same U.S. Drug Enforcement Administration and U.S. Food and Drug Administration standards set for the pharmaceutical industry, he said.
By following the product from seed to patient, Vyripharm aims to meet the needs of Texas’s program by creating guidelines that will ensure the products are safe and consistent.
“If you go to the drugstore to get Tylenol for your fever, you know you are getting the same level of acetaminophen wherever you go,” said Tori Strong, Ph.D., Vyripharm’s director of intellectual property and technology. “This is the same thing we want to do with cannabinoids.”
In addition, the company wants to research the specific effects of cannabinoids in individual patients.
“Soon, we will be able to find out how an initial dose of cannabinoids is being used by the body in a particular person, know exactly what works for them and be able to dose according to their characteristics,” Jackson said.
Baby shower help for 50 Veteran mothers at Miami VA hospital https://t.co/gzMBOgxeit via @wsvn
RT @bilalmomhammad: Great to see our pathology colleagues at @utmbhealth doing so well !!! @utmbnews @UTMB_Pathology @UTMBProvost https://t…
MD Anderson Cancer Center@MDAndersonNews
Daughter, caregiver Carrick Terhune shares the creative ways she supported her mom through #protontherapy for a rare #headandneckcancer: https://t.co/MpKEHxoaQO @MDAProtons #hncsm #endcancer
Researchers from Baylor College of Medicine, @MethodistHosp and @TexasChildrens receive a Specialized Center of Research grant to expand blood cancer therapy options. https://t.co/IcGckHPSBM #grants #cancer #research
RT @BruceTjadenMD: Here at @UTCVSurgery and @UTHealth, we are carrying out a #randomized #ClinicalTrial to compare #medical management vs #…
Veteran Affairs Office in Des Moines, IA holding coat drive https://t.co/IUDLZBpiZF via @weareiowa5news
RT @MillionHeartsUS: #Stroke risk increases with age, but strokes can (and do) happen at any age. Raise awareness of the importance of stro…
RT @BCMHouston_News: We are pleased to welcome Dr. Alastair Thompson to @bcmhouston! Dr. Thompson will lead #breastcancer surgical oncology…
MD Anderson Cancer Center@MDAndersonNews
“We’re really hopeful that we can identify a group of women who can get a much bigger and longer response,” says our @JenniferLitton of #immunotherapy to treat #breastcancer. #endcancer https://t.co/vv1JYis5rl
RT @HRSonline: Sudden #cardiacarrest claims 1 life every 90 secs. A few #SCA risk factors include a previous #heartattack, family history o…
The Dallas, TX VA and Vet Center teams met last week with leadership from the Urban Inter-Tribal Center of Texas to outline how their respective organizations can join forces to effectively reach and serve American Indian and Alaska Native Veterans. https://t.co/EBX1x6cPoV
RT @RiceUGPS: Lots of positive change coming to campus: the university is studying ways to create safe pathways for cyclists, and has also…
TAMU Health Sciences@TAMHSC
The Good Run . . . #MilesforSmiles in its 10th yearOn Nov. 3, the @TAMUdental student-led Miles for Smiles continues its stride at Exall Park in Dallas with its 10th annual runathon. https://t.co/5PFPnaDnOL#TAMHSC #AggieHealth #TAMUHealth #Dentistry #DentalStudents #TAMU https://t.co/NJaxKMawVq
University of Houston@UHouston
The John O'Quinn Foundation donates $3.5M to the UH College of Medicine, UH researchers envision in-home rehab for stroke patients, and Valenti students produce a web cooking show — here are your 60-second highlights of what's happening at UH #UHMoment https://t.co/1ork3iw0kz
CHI St. Luke's Health@CHI_StLukes
Sometimes it’s difficult to sift through the rumors to get the facts about #BreastCancer. We’re debunking five common myths, and they just might surprise you: https://t.co/pMnncNr4ul https://t.co/0HNfCjQYgI